1992;152:309 12. 250. Ho K-T, Miller TD, Hodge DO, et al. Use of a simple clinical score to predict prognosis of patients with normal or mildly abnormal resting electrocardiographic findings undergoing evaluation for coronary artery disease. Mayo Clin Proc. 2002;77:515 21. 251. Miller TD, Roger VL, Hodge DO, et al. A simple clinical score accurately predicts outcome in a community-based population undergoing stress testing. Am J Med. 2005;118:866 72. 252. Diamond GA, Kaul S. COURAGE under fire: on the management of stable coronary disease. J Am Coll Cardiol. 2007;50:1604 9. 253. Buckley DI, Fu R, Freeman M, et al. C-reactive protein as a risk factor for coronary heart disease: a systematic review and metaanalyses for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151: 483 95. 254. Oremus M, Raina PS, Santaguida P, et al. A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease. Clin Biochem. 2008;41:260 5. 255. Shah T, Casas JP, Cooper JA, et al. Critical appraisal of CRP mea- surement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epidemiol. 2009;38:217 31. 256. Heslop CL, Frohlich JJ, Hill JS. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascu- lar mortality after coronary angiography. J Am Coll Cardiol. 2010;55: 1102 9. 257. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735 52. 258. O Donoghue M, Morrow DA, Sabatine MS, et al. Lipoproteinasso- ciated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial. Circulation. 2006;113:1745 52. 259. 